Broken Stocks does not issue buy or sell recommendations. The site is a technical warning system that tracks structural decline depth and recency. Consult a licensed advisor before making investment decisions.

What sector is RXST in and how do its peers look?

RXST is classified under Healthcare (Medical Devices). There are currently 194 other Healthcare tickers on Broken Stocks, with a median decline of 35.8%.

Where is RXST trading within its 52-week range?

RXST is currently at 5.59, which is 2.5% of the way from its 52-week low of 5.30 to its 52-week high of 16.74.

Red List

RXSTRxSight, Inc.

Q: Why is RXST on Broken Stocks?

RXST qualifies for the Red List on decline depth. It is down 66.1% from its rolling 252-day high of 16.48 set on 2025-05-29, 364 days ago. Tiering is rules-based and reflects price action only — not company quality, management, or fundamentals.

Q: Is RXST a falling knife?

Not by the strict technical definition. RXST is down 66.1% from its 52-week high, but that high was set 364 days ago — more than 120 days. A falling knife is usually a recent breakdown from a fresh high, not an established multi-quarter downtrend. RXST is still on the Red List for decline depth, but the freshness component of a falling knife is missing. Tiering is rules-based and reflects price action only — not company quality, management, or fundamentals.

Healthcare · Medical Devices · micro-cap ($246M)

-66.1%

from rolling 252-day high of $16.48 set 2025-05-29 · 364d ago

Current

$5.59

Decline depth

-66.1%

Decline σ

5.7σ

TFC

5/5 bearish

Rolling 252-day high Up day Down day Last 90 trading days · data from Alpaca

Since tracking began

$RXST has been tracked since 2026-03-01. It was down 74.4% from its 52-week high then — now down -66.1%.

That's 9.7 percentage points deeper than the day it joined.

Decline from the 52-week high as it stood on 2026-03-02 (fixed anchor) → today. Split-adjusted, Alpaca. Observed history, not a forecast.

Structural break signals

RXST qualifies for the Red List on decline depth.

Decline depth

-66.1%

From rolling 252-day high of $16.48, 364d ago. Past the 40% Red List threshold.

Time-frame continuity

5/5 bearish

Latest bar across daily/weekly/monthly/quarterly/yearly time frames. A bar counts as bearish when it's a 2-Down or a red 3. Full bearish continuity — every time frame is broken.

Decline sigma

5.7σ

Drop from local high over the last 20 bars, expressed in units of the stock's typical daily volatility (4.64% per day). Past the ≥4σ Watch threshold.

The structural read

What price action says about RXST.

RXST qualifies for the Red List on decline depth — down -66.1% from its rolling 252-day high. Past the 40% threshold, the deepest tier in the taxonomy.

Cross-confirmation: also showing 5/5 bearish time frames.

Cross-confirmation: decline sigma also reads 5.7σ over 20 bars.

Upstream TFC read: bearish alignment, current phase daily. Last bar types — daily 2D (red), weekly 2D (red), monthly 2D (red).

Earnings on file: 2026-05-06. Tiering is unaffected by earnings dates — listings reflect price structure only.

52-week range

52W low $5.30 2.5% of range 52W high $16.74

Sector context · Healthcare

194 other Healthcare tickers are on Broken Stocks.

88 Red List

47 Amber

59 Watch

-35.8% Median decline

Worst in sector: OPRX (-77.1%). Least-bad: MRNA (-20.1%). See all Healthcare listings →

Questions about RXST

What people ask.

Why is RXST on Broken Stocks?

RXST qualifies for the Red List on decline depth. It is down -66.1% from its rolling 252-day high of $16.48, set on 2025-05-29 — 364d ago.

Is RXST a falling knife?

Not by the strict technical definition. RXST is down -66.1% from its 52-week high, but that high was set 364d ago — more than 120 days. A falling knife is usually a recent breakdown from a fresh high, not an established multi-quarter downtrend. RXST is still on the Red List for decline depth, but the freshness component of a falling knife is missing.

Is RXST a buy?

Broken Stocks does not issue buy or sell recommendations. The list is a rules-based technical warning system. It tracks structural decline depth and recency — not company quality, management, fundamentals, or news. Always do your own research and consult a licensed advisor.

Where is RXST trading inside its 52-week range?

At $5.59, RXST sits 2.5% of the way from its 52-week low ($5.30) to its 52-week high ($16.74). A reading below 25% indicates price is hugging the bottom of the range; above 75%, the top.

How fast has RXST been declining?

The current 66.1% decline accrued over 364d, which annualizes to roughly -66.3% per year. Annualized pace is a sanity check — a 30% decline in three months is a different signal than a 30% decline over two years.

How does RXST compare to its sector?

There are 194 other Healthcare tickers on Broken Stocks: 88 Red, 47 Amber, 59 Watch, with 108 showing recovering structural signals. Median sector decline is -35.8% — RXST's decline is deeper than the sector median.

Does RXST's earnings date affect its tier?

No. Tiering is decided purely by decline depth and recency of the rolling-high date. The earnings date on file (2026-05-06) is shown for reference only — listings can move tier between scans based on closing prices, regardless of fundamentals or news events.

← Back to the list Scan my portfolio →

RXSTRxSight, Inc.

$RXST has been tracked since 2026-03-01. It was down 74.4% from its 52-week high then — now down -66.1%.

RXST qualifies for the Red List on decline depth.

What price action says about RXST.

194 other Healthcare tickers are on Broken Stocks.

Closest decliners to RXST

What people ask.